ION BEAM APPLICATIONS (IBAB.BR) Stock Fundamental Analysis
Europe - EBR:IBAB - BE0003766806 - Common Stock
11.1 EUR
+0.06 (+0.54%)
Overall IBAB gets a fundamental rating of 4 out of 10. We evaluated IBAB against 59 industry peers in the Health Care Equipment & Supplies industry. There are concerns on the financial health of IBAB while its profitability can be described as average. IBAB is not valued too expensively and it also shows a decent growth rate.
1. Profitability
1.1 Basic Checks
IBAB had positive earnings in the past year.
IBAB had a negative operating cash flow in the past year.
Of the past 5 years IBAB 4 years were profitable.
In multiple years IBAB reported negative operating cash flow during the last 5 years.
1.2 Ratios
IBAB's Return On Assets of 1.50% is in line compared to the rest of the industry. IBAB outperforms 44.07% of its industry peers.
IBAB has a better Return On Equity (8.34%) than 67.80% of its industry peers.
Looking at the Return On Invested Capital, with a value of 11.77%, IBAB belongs to the top of the industry, outperforming 86.44% of the companies in the same industry.
IBAB had an Average Return On Invested Capital over the past 3 years of 6.33%. This is below the industry average of 8.90%.
The last Return On Invested Capital (11.77%) for IBAB is above the 3 year average (6.33%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.5% | ||
| ROE | 8.34% | ||
| ROIC | 11.77% |
ROA(3y)0.32%
ROA(5y)1.58%
ROE(3y)1.66%
ROE(5y)6.12%
ROIC(3y)6.33%
ROIC(5y)6.79%
1.3 Margins
With a Profit Margin value of 1.86%, IBAB perfoms like the industry average, outperforming 44.07% of the companies in the same industry.
IBAB's Profit Margin has declined in the last couple of years.
Looking at the Operating Margin, with a value of 5.60%, IBAB is in line with its industry, outperforming 40.68% of the companies in the same industry.
In the last couple of years the Operating Margin of IBAB has grown nicely.
IBAB has a worse Gross Margin (33.32%) than 76.27% of its industry peers.
IBAB's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 5.6% | ||
| PM (TTM) | 1.86% | ||
| GM | 33.32% |
OM growth 3Y8.91%
OM growth 5Y47.94%
PM growth 3Y14.44%
PM growth 5Y-7.16%
GM growth 3Y-1.07%
GM growth 5Y0.22%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), IBAB is creating some value.
The number of shares outstanding for IBAB has been increased compared to 1 year ago.
IBAB has less shares outstanding than it did 5 years ago.
The debt/assets ratio for IBAB is higher compared to a year ago.
2.2 Solvency
Based on the Altman-Z score of 1.45, we must say that IBAB is in the distress zone and has some risk of bankruptcy.
The Altman-Z score of IBAB (1.45) is worse than 61.02% of its industry peers.
IBAB has a Debt/Equity ratio of 0.23. This is a healthy value indicating a solid balance between debt and equity.
With a decent Debt to Equity ratio value of 0.23, IBAB is doing good in the industry, outperforming 66.10% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.23 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 1.45 |
ROIC/WACC1.64
WACC7.18%
2.3 Liquidity
A Current Ratio of 0.95 indicates that IBAB may have some problems paying its short term obligations.
IBAB has a Current ratio of 0.95. This is amonst the worse of the industry: IBAB underperforms 84.75% of its industry peers.
A Quick Ratio of 0.63 indicates that IBAB may have some problems paying its short term obligations.
IBAB's Quick ratio of 0.63 is on the low side compared to the rest of the industry. IBAB is outperformed by 83.05% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.95 | ||
| Quick Ratio | 0.63 |
3. Growth
3.1 Past
IBAB shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 110.64%, which is quite impressive.
Measured over the past 5 years, IBAB shows a small growth in Earnings Per Share. The EPS has been growing by 3.99% on average per year.
Looking at the last year, IBAB shows a quite strong growth in Revenue. The Revenue has grown by 18.44% in the last year.
Measured over the past years, IBAB shows a quite strong growth in Revenue. The Revenue has been growing by 12.01% on average per year.
EPS 1Y (TTM)110.64%
EPS 3Y33.53%
EPS 5Y3.99%
EPS Q2Q%74.97%
Revenue 1Y (TTM)18.44%
Revenue growth 3Y16.76%
Revenue growth 5Y12.01%
Sales Q2Q%47.69%
3.2 Future
IBAB is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 58.13% yearly.
Based on estimates for the next years, IBAB will show a small growth in Revenue. The Revenue will grow by 2.63% on average per year.
EPS Next Y208.45%
EPS Next 2Y114.61%
EPS Next 3Y71%
EPS Next 5Y58.13%
Revenue Next Year21.26%
Revenue Next 2Y12.69%
Revenue Next 3Y9.84%
Revenue Next 5Y2.63%
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
With a Price/Earnings ratio of 19.47, IBAB is valued on the expensive side.
83.05% of the companies in the same industry are more expensive than IBAB, based on the Price/Earnings ratio.
IBAB's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 27.41.
With a Price/Forward Earnings ratio of 9.98, the valuation of IBAB can be described as very reasonable.
IBAB's Price/Forward Earnings ratio is rather cheap when compared to the industry. IBAB is cheaper than 91.53% of the companies in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 22.88. IBAB is valued rather cheaply when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 19.47 | ||
| Fwd PE | 9.98 |
4.2 Price Multiples
IBAB's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. IBAB is cheaper than 88.14% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | 7.73 |
4.3 Compensation for Growth
IBAB's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as IBAB's earnings are expected to grow with 71.00% in the coming years.
PEG (NY)0.09
PEG (5Y)4.89
EPS Next 2Y114.61%
EPS Next 3Y71%
5. Dividend
5.1 Amount
IBAB has a Yearly Dividend Yield of 1.44%.
Compared to an average industry Dividend Yield of 2.30, IBAB pays a bit more dividend than its industry peers.
IBAB's Dividend Yield is slightly below the S&P500 average, which is at 2.38.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.44% |
5.2 History
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
IBAB pays out 52.84% of its income as dividend. This is a bit on the high side, but may be sustainable.
DP52.84%
EPS Next 2Y114.61%
EPS Next 3Y71%
EBR:IBAB (9/19/2025, 1:28:39 PM)
11.1
+0.06 (+0.54%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners25.71%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap336.11M
Analysts80
Price Target14.96 (34.77%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.44% |
Yearly Dividend0.17
Dividend Growth(5Y)N/A
DP52.84%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-7.95%
PT rev (3m)-7.95%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-20.44%
EPS NY rev (3m)-20.44%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)4.21%
Revenue NY rev (3m)4.04%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 19.47 | ||
| Fwd PE | 9.98 | ||
| P/S | 0.67 | ||
| P/FCF | N/A | ||
| P/OCF | N/A | ||
| P/B | 3.03 | ||
| P/tB | 3.94 | ||
| EV/EBITDA | 7.73 |
EPS(TTM)0.57
EY5.14%
EPS(NY)1.11
Fwd EY10.02%
FCF(TTM)-0.59
FCFYN/A
OCF(TTM)-0.35
OCFYN/A
SpS16.45
BVpS3.66
TBVpS2.82
PEG (NY)0.09
PEG (5Y)4.89
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.5% | ||
| ROE | 8.34% | ||
| ROCE | 18.95% | ||
| ROIC | 11.77% | ||
| ROICexc | 23.1% | ||
| ROICexgc | 35.13% | ||
| OM | 5.6% | ||
| PM (TTM) | 1.86% | ||
| GM | 33.32% | ||
| FCFM | N/A |
ROA(3y)0.32%
ROA(5y)1.58%
ROE(3y)1.66%
ROE(5y)6.12%
ROIC(3y)6.33%
ROIC(5y)6.79%
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)10.19%
ROCE(5y)10.93%
ROICexcg growth 3YN/A
ROICexcg growth 5Y53.77%
ROICexc growth 3Y-88.07%
ROICexc growth 5Y51.35%
OM growth 3Y8.91%
OM growth 5Y47.94%
PM growth 3Y14.44%
PM growth 5Y-7.16%
GM growth 3Y-1.07%
GM growth 5Y0.22%
F-Score5
Asset Turnover0.81
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.23 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | 0.65 | ||
| Cap/Depr | 63.41% | ||
| Cap/Sales | 1.49% | ||
| Interest Coverage | 20.73 | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 0.95 | ||
| Quick Ratio | 0.63 | ||
| Altman-Z | 1.45 |
F-Score5
WACC7.18%
ROIC/WACC1.64
Cap/Depr(3y)79.57%
Cap/Depr(5y)64.6%
Cap/Sales(3y)2.05%
Cap/Sales(5y)1.81%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)110.64%
EPS 3Y33.53%
EPS 5Y3.99%
EPS Q2Q%74.97%
EPS Next Y208.45%
EPS Next 2Y114.61%
EPS Next 3Y71%
EPS Next 5Y58.13%
Revenue 1Y (TTM)18.44%
Revenue growth 3Y16.76%
Revenue growth 5Y12.01%
Sales Q2Q%47.69%
Revenue Next Year21.26%
Revenue Next 2Y12.69%
Revenue Next 3Y9.84%
Revenue Next 5Y2.63%
EBIT growth 1Y269.56%
EBIT growth 3Y27.16%
EBIT growth 5Y65.71%
EBIT Next Year224.83%
EBIT Next 3Y67.74%
EBIT Next 5Y52.33%
FCF growth 1Y43.86%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y46.44%
OCF growth 3YN/A
OCF growth 5YN/A